Do you want to read an article? Please log in or register.
Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study
Cough
RECOMMENDED
Related content
Cough
Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy
Ann Allergy Asthma Immunol.
Sadeghi MH, Wright CE, Hart S, Crooks M, Morice A
doi: 10.1016/j.anai.2017.12.004.
RECOMMENDED
Pulmonary Fibrosis
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Anstrom KJ, Noth I, Flaherty KR, Edwards RH, Albright J, Baucom A, Brooks M, Clark AB, Clausen ES, Durheim MT, Kim DY, Kirchner J, Oldham JM, Snyder LD, Wilson AM, Wisniewski SR, Yow E, Martinez FJ, CleanUP-IPF Study Team
doi: 10.1186/s12931-020-1326-1.
Pulmonary Fibrosis
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
EBioMedicine.
Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM, Kritchevsky SB, Musi N, Kirkland JL
doi: 10.1016/j.ebiom.2018.12.052.
RECOMMENDED
Pulmonary Fibrosis
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Lancet Respir Med.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L
doi: 10.1016/S2213-2600
RECOMMENDED
Pulmonary Fibrosis
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Chilvers MA, Davies JC, Milla C, Tian S, Han Z, Cornell AG, Owen CA, Ratjen F
doi: 10.1016/S2213-2600(20)30517-8
Cough
Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough
JAMA Otolaryngol Head Neck Surg.
Giliberto JP, Dibildox D, Merati A
doi: 10.1001/
RECOMMENDED
Cough
Impaired cough suppression in chronic refractory cough
Eur Respir J.
Cho PSP, Fletcher HV, Turner RD, Jolley CJ, Birring SS
doi: 10.1183/
COPD
Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease
J Mol Med (Berl).
Seo M, Qiu W, Bailey W, Criner GJ, Dransfield MT, Fuhlbrigge AL, Reilly JJ, Scholand MB, Castaldi P, Chase R, Parker M, Saferali A, Yun JH, Crapo JD, Cho MH, Beaty TH, Silverman EK, Hersh CP
doi: 10.1007/s00109-018-1708-8.
COMMENTED
COPD
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
Lancet Respir Med.
Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C
doi: 10.1016/S2213-2600